Devereaux P, Marcucci M, Painter TW, Conen D, Lomivorotov V, Sessler DI, et al. Tranexamic acid in patients undergoing noncardiac surgery. N Engl J Med. 2022;386(21):1986–97.

Article  CAS  PubMed  Google Scholar 

Pacheco LD, Clifton RG, Saade GR, Weiner SJ, Parry S, Thorp JM Jr, et al. Tranexamic acid to prevent obstetrical hemorrhage after cesarean delivery. N Engl J Med. 2023;388(15):1365–75. https://doi.org/10.1056/NEJMoa2207419.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoh BL, Ko NU, Amin-Hanjani S, Chou S-Y, Cruz-Flores S, Dangayach NS, et al. 2023 guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke. 2023;54(7):e314–70. https://doi.org/10.1161/STR.0000000000000436.

Article  PubMed  Google Scholar 

Treggiari MM, Rabinstein AA, Busl KM, Caylor MM, Citerio G, Deem S, et al. Guidelines for the neurocritical care management of aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2023;39(1):1–28. https://doi.org/10.1007/s12028-023-01713-5.

Article  PubMed  Google Scholar 

Greenberg SM, Ziai WC, Cordonnier C, Dowlatshahi D, Francis B, Goldstein JN, et al. 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke. 2022;53(7):e282–361. https://doi.org/10.1161/STR.0000000000000407.

Article  CAS  PubMed  Google Scholar 

Karl V, Thorn S, Mathes T, Hess S, Maegele M. Association of tranexamic acid administration with mortality and thromboembolic events in patients with traumatic injury: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(3): e220625. https://doi.org/10.1001/jamanetworkopen.2022.0625.

Article  PubMed  PubMed Central  Google Scholar 

Sprigg N, Flaherty K, Appleton JP, Al-Shahi Salman R, Bereczki D, Beridze M, et al. Tranexamic acid for hyperacute primary intracerebral haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. Lancet. 2018;391(10135):2107–15. https://doi.org/10.1016/S0140-6736(18)31033-X.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nie X, Liu J, Liu D, Zhou Q, Duan W, Pu Y, et al. Haemostatic therapy in spontaneous intracerebral haemorrhage patients with high-risk of haematoma expansion by CT marker: a systematic review and meta-analysis of randomised trials. Stroke Vasc Neurol. 2021;6(2):170–9. https://doi.org/10.1136/svn-2021-000941.

Article  PubMed  PubMed Central  Google Scholar 

Murao S, Nakata H, Roberts I, Yamakawa K. Effect of tranexamic acid on thrombotic events and seizures in bleeding patients: a systematic review and meta-analysis. Crit Care. 2021;25(1):380. https://doi.org/10.1186/s13054-021-03799-9.

Article  PubMed  PubMed Central  Google Scholar 

Wafaisade A, Lefering R, Bouillon B, Bohmer AB, Gassler M, Ruppert M, et al. Prehospital administration of tranexamic acid in trauma patients. Crit Care. 2016;20(1):143. https://doi.org/10.1186/s13054-016-1322-5.

Article  PubMed  PubMed Central  Google Scholar 

Dhingra P, Yeung M, Lang E. Tranexamic acid in emergency medicine. An overview of reviews. Intern Emerg Med. 2023;18(1):211–8. https://doi.org/10.1007/s11739-022-03155-x.

Article  PubMed  Google Scholar 

van Rossum J, Wintzen AR, Endtz LJ, Schoen JH, de Jonge H. Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial. Ann Neurol. 1977;2(3):238–42. https://doi.org/10.1002/ana.410020310.

Article  PubMed  Google Scholar 

Chandra B. Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial. Ann Neurol. 1978;3(6):502–4. https://doi.org/10.1002/ana.410030607.

Article  CAS  PubMed  Google Scholar 

Maurice-Williams RS. Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms? Br Med J. 1978;1(6118):945–7. https://doi.org/10.1136/bmj.1.6118.945.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaste M, Ramsay M. Tranexamic acid in subarachnoid haemorrhage. A double-blind study. Stroke. 1979;10(5):519–22. https://doi.org/10.1161/01.str.10.5.519.

Article  CAS  PubMed  Google Scholar 

Fodstad H, Forssell A, Liliequist B, Schannong M. Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial. Neurosurgery. 1981;8(2):158–65. https://doi.org/10.1227/00006123-198102000-00004.

Article  CAS  PubMed  Google Scholar 

Vermeulen M, Lindsay KW, Murray GD, Cheah F, Hijdra A, Muizelaar JP, et al. Antifibrinolytic treatment in subarachnoid hemorrhage. N Engl J Med. 1984;311(7):432–7. https://doi.org/10.1056/NEJM198408163110703.

Article  CAS  PubMed  Google Scholar 

Tsementzis SA, Hitchcock ER, Meyer CH. Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study. Acta Neurochir (Wien). 1990;102(1–2):1–10. https://doi.org/10.1007/BF01402177.

Article  CAS  PubMed  Google Scholar 

Roos Y. Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. STAR study group. Neurology. 2000;54(1):77–82. https://doi.org/10.1212/wnl.54.1.77.

Article  CAS  PubMed  Google Scholar 

Hillman J, Fridriksson S, Nilsson O, Yu Z, Saveland H, Jakobsson KE. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg. 2002;97(4):771–8. https://doi.org/10.3171/jns.2002.97.4.0771.

Article  CAS  PubMed  Google Scholar 

Perel P, Al-Shahi Salman R, Kawahara T, Morris Z, Prieto-Merino D, Roberts I, et al. CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury—a nested randomised, placebo-controlled trial. Health Technol Assess. 2012;16(13):iii–xii, 1–54. https://doi.org/10.3310/hta16130.

Yutthakasemsunt S, Kittiwatanagul W, Piyavechvirat P, Thinkamrop B, Phuenpathom N, Lumbiganon P. Tranexamic acid for patients with traumatic brain injury: a randomized, double-blinded, placebo-controlled trial. BMC Emerg Med. 2013;13:20. https://doi.org/10.1186/1471-227X-13-20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sprigg N, Renton CJ, Dineen RA, Kwong Y, Bath PM. Tranexamic acid for spontaneous intracerebral hemorrhage: a randomized controlled pilot trial (ISRCTN50867461). J Stroke Cerebrovasc Dis. 2014;23(6):1312–8. https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.11.007.

Article  PubMed  Google Scholar 

Fakharian E, Abedzadeh-Kalahroudi M, Atoof F. Effect of tranexamic acid on prevention of pemorrhagic mass growth in patients with traumatic brain injury. World Neurosurg. 2018;109:e748–53. https://doi.org/10.1016/j.wneu.2017.10.075.

Article  PubMed  Google Scholar 

Roberts I, Shakur-Still H, Aeron-Thomas A, Belli A, Brenner A, Chaudary MA, et al. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet. 2019;394(10210):1713–23. https://doi.org/10.1016/S0140-6736(19)32233-0.

Article  CAS  Google Scholar 

Chakroun-Walha O, Samet A, Jerbi M, Nasri A, Talbi A, Kanoun H, et al. Benefits of the tranexamic acid in head trauma with no extracranial bleeding: a prospective follow-up of 180 patients. Eur J Trauma Emerg Surg. 2019;45(4):719–26. https://doi.org/10.1007/s00068-018-0974-z.

Article  PubMed  Google Scholar 

Ebrahimi P, Mozafari J, Ilkhchi RB, Hanafi MG, Mousavinejad M. Intravenous tranexamic acid for subdural and epidural intracranial hemorrhage: randomized, double-blind, placebo-controlled trial. Rev Recent Clin Trials. 2019;14(4):286–91. https://doi.org/10.2174/1574887114666190620112829.

Article  CAS  PubMed  Google Scholar 

Meretoja A, Yassi N, Wu TY, Churilov L, Sibolt G, Jeng JS, et al. Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 2020;19(12):980–7. https://doi.org/10.1016/S1474-4422(20)30369-0.

Article  CAS  PubMed